RECRUITINGOBSERVATIONAL
Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer
Retrospective and Prospective Evaluation of the Impact of Innovative and Conventional Treatments and of Clinical Variables on the Outcome of Thyroid Cancer
About This Trial
DTC has a generally favorable prognosis. The possibility to discriminate between patients with aggressive tumors and those with a more indolent behavior may reduce the need for unnecessary treatments. Aim of this observational study is to evaluate how anamnestic, clinical, and histopathological variables may influence the outcome of the enrolled patients, both regarding morbidity and mortality and in terms of therapeutic choices. The study aims to evaluate the prognostic impact of the therapeutic interventions in terms of efficacy and regarding the appearance of adverse events.
Who May Be Eligible (Plain English)
Who May Qualify:
\- thyroid cancer diagnosis
Who Should NOT Join This Trial:
- patients unable to sign willing to sign a consent form
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
\- thyroid cancer diagnosis
Exclusion Criteria:
* patients unable to sign informed consent
Locations (1)
Istituto Auxologico Italiano, IRCCS
Milan, Italy